Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.85 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 3/20 | 0.80 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.80 |
| ▸ | AURKA | O14965 | 2/20 | 0.80 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.80 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27966667 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL380682 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL380683 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20348156 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL23014594 | 0.99 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL19359081 | 0.99 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29651526 | 0.99 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL21410668 | 0.99 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29651531 | 0.99 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL15798371 | 0.97 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638753-A2 | PRODUCTION OF CANNABINOIDS AND ENGINEERED CELLS THEREFOR | Cellibre, Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| WO-2024138205-A2 | PRODUCTION OF CANNABINOIDS AND ENGINEERED CELLS THEREFOR | CELLIBRE, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| US-20250361532-A1 | BIDIRECTIONAL MULTI-ENZYMATIC SCAFFOLDS FOR BIOSYNTHESIZING CANNABINOIDS | KHONA SCIENT HOLDINGS INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4638753-A2 | PRODUCTION OF CANNABINOIDS AND ENGINEERED CELLS THEREFOR | Cellibre, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-12385072-B2 | Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids | KHONA SCIENTIFIC HOLDINGS, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-20230265465-A1 | BIDIRECTIONAL MULTI-ENZYMATIC SCAFFOLDS FOR BIOSYNTHESIZING CANNABINOIDS | ORLADY, PAUL | 2023-08-24 | — | — | US | disclosed |
| CN-116240122-A | Co-produced ethyl caproate and saccharomyces cerevisiae strain as well as construction method and application thereof | 天津科技大学 | 2023-06-09 | — | — | CN | disclosed |
| US-11525148-B2 | Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids | KHONA SCIENTIFIC HOLDINGS, INC. (US) | 2022-12-13 | — | — | US | disclosed |
| CN-108368524-B | Process for producing 3-oxoadipic acid | 东丽株式会社 | 2022-05-06 | — | — | CN | disclosed |